The Senate is set to confirm Erica Schwartz as the new director of the Centers for Disease Control and Prevention (CDC) on Wednesday. Senate Majority Leader John Thune has scheduled the vote, which would appoint the agency’s first permanent director in nearly a year.
Schwartz’s confirmation marks the first Senate-confirmed leader since Susan Monarez was dismissed last August after disagreements with Health Secretary Robert F. Kennedy Jr regarding vaccine policies. Schwartz was backed by the Senate Health Committee, with Chairman Bill Cassidy expressing his support after initially having reservations. All Republicans voted in favor, along with Democratic Senator Tim Kaine.
The Trump administration faced challenges appointing a CDC director, with initial nominee Dave Weldon withdrawing due to insufficient votes amid concerns about his preparedness and vaccine stance.
Schwartz steps into a role within an agency that has faced instability since President Trump assumed office. The CDC has experienced decreased morale and lost over a quarter of its workforce due to layoffs and resignations. During the confirmation hearing, Cassidy queried Schwartz’s ability to shield the CDC from political interference and resist pressure from Kennedy not aligned with scientific evidence. Despite initial skepticism, Cassidy endorsed Schwartz, citing reassurances from the Department of Health and Human Services, including website changes related to autism and vaccines.
Cassidy stated, “I am confident that she knows what she is doing and will stand against those who don’t,” prior to advancing her nomination.
Senator Bernie Sanders opposed the nomination, questioning if Trump’s administration enrollees can counter anti-science rhetoric and conspiracy theories.
Meanwhile, the FDA granted marketing authorization to four flavored nicotine pouches from Helix Innovations. This decision is part of the agency’s tobacco review initiative. Additionally, hemp THC producers received temporary relief due to a Senate spending bill delaying their product ban. Research highlights the cost implications of managing the 2025 measles outbreak, with a substantial $5.4 million price tag.
The Senate Homeland Security & Governmental Affairs Committee plans a vote concerning Anthony Fauci’s alleged contempt of Congress following his refusal to answer questions in a hearing.
In other health news, the cyclospora outbreak has resulted in fatalities, while various states address challenges related to Medicaid and disease outbreaks.
Tags: Bill Cassidy, John Thune